- CytRx (OTCQB:CYTR) said it is renaming as LadRx Corporation, effective Sept. 26.
- The company added that it will trade under the ticker CYTR until the new symbol has been approved by FINRA
- LADR stands for Linker Activated Drug Release, a small organic backbone that can be attached to chemotherapeutics, the company said in a Sept. 23 press release.
- CytRx noted that the first-gen LADR-based drug aldoxorubicin is currently in a phase 2 trial for pancreatic cancer, and has been licensed to Immunity Bio.
- "On September 26, 2022, the Company’s website will be www.ladrxcorp.com. This name reflects our unique product platform that has given rise to one clinical drug, Aldoxorubicin, and four pre-clinical therapeutics targeted against cancer, LADRs 7, 8, 9, and 10," said CEO Stephen Snowdy.
CytRx to rename as LadRx
Recommended For You
More Trending News
About LADX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LADX | - | - |
LadRx Corporation |